Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

NCT ID: NCT00692796

Last Updated: 2017-03-29

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2008-04-30
• Study Completion Date: 2010-03-31

Brief Summary

The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). Pulmonary rehabilitation has already been shown to benefit patients with other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD). We believe that pulmonary rehabilitation will benefit patients with IPF as well.

Detailed Description

The goals of this project are to assess the effect of PR on a number of important outcomes in patients with IPF. Once enrolled in the study, subjects will complete a battery of questionnaires and tests that assess symptoms, quality of life, cognition, and mental health, and then subjects will complete a six week outpatient PR program (at National Jewish Medical and Research Center or other PR programs). Subjects will complete the same battery of questionnaires and tests immediately after completion of the PR program and again six months later.

Conditions

Idiopathic Pulmonary Fibrosis

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT

Study Groups

1

Group Type: EXPERIMENTAL

Pulmonary rehabilitation

Intervention Type: OTHER

Pulmonary rehabilitation is a multi-disciplinary program that includes exercise training, disease education, psychosocial education (e.g., stress management, coping with chronic illness) and nutrition education.

Interventions

Pulmonary rehabilitation

Pulmonary rehabilitation is a multi-disciplinary program that includes exercise training, disease education, psychosocial education (e.g., stress management, coping with chronic illness) and nutrition education.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age 40 years or older
• Diagnosis of IPF according to American Thoracic Society criteria

Exclusion Criteria

• Patients who have completed a PR program within the last two years
• Patients with unstable medical conditions that would make PR unsafe

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Mordecai Palliative Care Research Fund

UNKNOWN

Sponsor Role: collaborator

National Jewish Health

OTHER

Sponsor Role: lead

Responsible Party

National Jewish Medical and Research Center

Principal Investigators

Jeff Swigris, DO, MS

Role: PRINCIPAL_INVESTIGATOR

National Jewish Medical and Research Center (Jeffrey J. Swigris, DO, MS; Assistant Professor of Medicine)

Locations

National Jewish Medical and Research Center

Denver, Colorado, United States

Countries

United States

References

Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, Brown KK, Wamboldt FS. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011 Jun;56(6):783-9. doi: 10.4187/respcare.00939. Epub 2011 Feb 11.

Reference Type: DERIVED

PMID: 21333082 (View on PubMed)

Other Identifiers

NJMRC HS 1603 substudy

Identifier Type: -

Identifier Source: org_study_id